Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
27759 | 182 | 19.7 | 60% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
2717 | 2782 | INCOMPATIBILITIES//AMERICAN JOURNAL OF HOSPITAL PHARMACY//PSEUDOLITHIASIS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | PSEUDOLITHIASIS | Author keyword | 18 | 83% | 5% | 10 |
2 | BILIARY PSEUDOLITHIASIS | Author keyword | 14 | 100% | 4% | 7 |
3 | INSOLUBLE MICROPARTICLE | Author keyword | 3 | 100% | 2% | 3 |
4 | LIGHT OBSCURATION PARTICLE COUNTER | Author keyword | 3 | 100% | 2% | 3 |
5 | PSEUDOCHOLELITHIASIS | Author keyword | 3 | 100% | 2% | 3 |
6 | CEFTRIAXONE THERAPY | Author keyword | 1 | 100% | 1% | 2 |
7 | CASE RELATED PAYMENT | Author keyword | 1 | 50% | 1% | 1 |
8 | CHILDRENS UROLITHIASIS TREATMENT | Address | 1 | 50% | 1% | 1 |
9 | FIXED REIMBURSEMENT RATES | Author keyword | 1 | 50% | 1% | 1 |
10 | KLIN POLIKLIN THORAX GEFAS IRURG | Address | 1 | 50% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BILIARY PSEUDOLITHIASIS | 36 | 69% | 17% | 31 |
2 | CALCIUM CEFTRIAXONE | 21 | 78% | 8% | 14 |
3 | GALLBLADDER SLUDGE | 8 | 41% | 9% | 16 |
4 | PSEUDOLITHIASIS | 7 | 48% | 6% | 11 |
5 | FEBRILE GRANULOCYTOPENIC CHILDREN | 2 | 67% | 1% | 2 |
6 | CLINICAL PHARMACEUTICS | 1 | 100% | 1% | 2 |
7 | ERYTHROCYTE BOUND BILIRUBIN | 1 | 100% | 1% | 2 |
8 | INDUCED CHOLELITHIASIS | 1 | 100% | 1% | 2 |
9 | CEFTRIAXONE SODIUM | 1 | 40% | 1% | 2 |
10 | DRUG COMPATIBILITY | 1 | 50% | 1% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Safety of ceftriaxone sodium at extremes of age | 2008 | 10 | 50 | 48% |
Adverse reaction to ceftriaxone in a 28-day-old infant undergoing urgent craniotomy due to epidural hematoma: review of neonatal biliary pseudolithiasis | 2015 | 0 | 34 | 41% |
METHODS OF QUANTITATIVE MICROBIOLOGICAL ANALYSES THAT SUPPORT THE DIAGNOSIS, TREATMENT, AND PROGNOSIS OF HUMAN INFECTION | 1981 | 11 | 3 | 33% |
"New macrolides" | 1998 | 0 | 16 | 6% |
ANTI-MICROBIAL DRUGS AND INFECTIONS IN AMBULATORY PATIENTS - SOME PROBLEMS AND PERSPECTIVES | 1983 | 5 | 18 | 11% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CHILDRENS UROLITHIASIS TREATMENT | 1 | 50% | 0.5% | 1 |
2 | KLIN POLIKLIN THORAX GEFAS IRURG | 1 | 50% | 0.5% | 1 |
3 | PEDIAT SURG TRAINING PROGRAM | 1 | 50% | 0.5% | 1 |
4 | ANESTHESIOL INTES CARE | 0 | 33% | 0.5% | 1 |
5 | MED PROTE UNIT MED | 0 | 33% | 0.5% | 1 |
6 | INTERDISCIPLINARY HLTH ECON | 0 | 20% | 0.5% | 1 |
7 | PEDIAT ANESTHESIOL INTENS THER Y | 0 | 17% | 0.5% | 1 |
8 | PETER LOUGHEED HOSP | 0 | 10% | 0.5% | 1 |
9 | ALBERTA HLTH SERV CRIT CARE MED | 0 | 100% | 0.5% | 1 |
10 | CHA HOP ENFANT JESUS ANESTHESIOL | 0 | 100% | 0.5% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000160981 | CHEMOTHERAPY-TOKYO//JAPANESE JOURNAL OF ANTIBIOTICS//RANCHI VET SCI ANIM HUSB |
2 | 0.0000143926 | FETAL GALLBLADDER//FETAL GALLSTONES//HEPATIC CRISIS |
3 | 0.0000139228 | CAS 396 01 0//CRYSTALLURIA//CALCULI ANALYSIS |
4 | 0.0000085002 | INTRAVENOUS INFUSION SETS//LIPOSORBER//ACHIRUS LINEATUS |
5 | 0.0000070281 | ANTIMICROBIAL STEWARDSHIP//ANTIBIOTIC STEWARDSHIP//ANTIBIOTIC ROTATION |
6 | 0.0000064482 | CROSS CULTURAL COOPERATION//GLOBAL BUDGET PAYMENT SYSTEM//IDENTIFICATION OF NEEDS |
7 | 0.0000063939 | ACADEMIC DETAILING//DRUG UTILIZATION REVIEW//ADVANCED PULMONARY DISEASE |
8 | 0.0000060838 | CHOLESTEROL CRYSTALLIZATION//BILIARY PROTEINS//CHOLESTEROL NUCLEATION |
9 | 0.0000058168 | BUREAU BARRIERE SYNDROME//RETROGRADE VENOUS PERFUSION//FB RATIO |
10 | 0.0000048616 | CASE RELATED PAYMENT//COMPARATIVE STATISTICS//DAVID GIFFEN MED |